Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study.
Diabetes Obes Metab
; 24(1): 160-165, 2022 01.
Article
in English
| MEDLINE | ID: covidwho-1560638
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Immunogenicity, Vaccine
/
Glycemic Control
/
COVID-19 Vaccines
/
COVID-19
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Diabetes Obes Metab
Journal subject:
Endocrinology
/
Metabolism
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS